Maze Therapeutics, Inc. (MAZE)

NGM – Real Time Price. Currency in USD

27.03

-0.28 (-1.03%)

Market open: Aug 12, 2026, 10:19 AM EDT

27.50

+0.19 (0.70%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

11.08.2026

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Enrollment in Phase 2 HORIZON trial of MZE829 on track; data from all cohorts expected in late 2026 or early 2027 Phase 2 CIPheR trial of MZE782 in PKU initiated and enrollment ongoing; topline data expected in 2027 Phase 2 trial of MZE782 in CKD on track for H1 2027 initiation Strong balance sheet with $495 million in cash, cash equivalents and marketable securities supports expected runway into 2029 SOUTH SAN FRANCISCO, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today reported financial results for the second quarter ended June 30, 2026, highlighting recent progress and business updates.

Videos

No Data

There is no data to display

Press releases

11.08.2026

Maze Therapeutics, Inc. (MAZE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Videos

No Data

Press releases

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Videos

No Data

Press releases

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Search stocks

Maze Therapeutics, Inc. (MAZE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Videos

No Data

Press releases

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Videos

No Data

Press releases

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights